✦ LIBER ✦

Panitumumab Monotherapy as a Second-line Treatment in Metastasised Colorectal Cancer: A Single Centre Experience

✍ Scribed by van Hellemond, I.E.G.; Creemers, G.J.; van Warmerdam, L.J.C.; de Jong, F.A.; Koornstra, R.H.T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVA

✍ F. Giuliani; P. Cito; M. Porcelli; A. Misino; A. Latorre; N. Silvestris; M. Guid 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Tamoxifen in the treatment of recurrent,

✍ C. Pisano; F.P. Magazzino; S. Greggi; S. Losito; R. Franco; G.S. Bruni; G. Facch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 36 KB

An Open-label, Single-arm, Phase 2 Trial

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Cetuximab and irinotecan as third-line t

✍ Coppola, R; Beomonte Zobel, B; Trodella, L; Tonini, G; Vincenzi, B; Santini, D; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

14LBA Randomized phase 3 study of panitu

✍ M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Cost–effectiveness of UGT1A1 genotyping

✍ Obradovic, Marko; Mrhar, Ales; Kos, Mitja 📂 Article 📅 2008 🏛 Future Medicine 🌐 English ⚖ 319 KB